Literature DB >> 3425283

Hematogenous infection after knee arthroplasty.

S Bengtson1, G Blomgren, K Knutson, A Wigren, L Lidgren.   

Abstract

Twenty-five hematogenously infected knee arthroplasties in 20 patients (17 with rheumatoid arthritis and 3 with arthrosis) were followed for 3 years. Staphylococcus aureus was the major infecting organism. Three patients with four arthroplasties died of sepsis. Two patients had removal of the arthroplasty, one of which resulted in an above-the-knee amputation. Four out of five arthrodeses fused. Two knees healed after early debridement and two healed without surgery. Ten knees had successful revision arthroplasty. Rheumatoid arthritis and constrained prostheses increase the risk of hematogenous infection. Any infection and especially cutaneous lesions in a patient with a knee arthroplasty should be treated vigorously.

Entities:  

Mesh:

Year:  1987        PMID: 3425283     DOI: 10.3109/17453678709146393

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  5 in total

1.  Pathogenesis and prevention of biomaterial centered infections.

Authors:  B Gottenbos; H J Busscher; H C Van Der Mei; P Nieuwenhuis
Journal:  J Mater Sci Mater Med       Date:  2002-08       Impact factor: 3.896

2.  Late hematogenous infection of subcutaneous implants in rats.

Authors:  B Gottenbos; F Klatter; H C Van Der Mei; H J Busscher; P Nieuwenhuis
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

Review 3.  Antimicrobial prophylaxis in adults.

Authors:  Mark J Enzler; Elie Berbari; Douglas R Osmon
Journal:  Mayo Clin Proc       Date:  2011-07       Impact factor: 7.616

4.  Infection control rate of irrigation and débridement for periprosthetic joint infection.

Authors:  Loukas Koyonos; Benjamin Zmistowski; Craig J Della Valle; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2011-11       Impact factor: 4.176

Review 5.  The Swedish Knee Arthroplasty Register: a review.

Authors:  O Robertsson; J Ranstam; M Sundberg; A W-Dahl; L Lidgren
Journal:  Bone Joint Res       Date:  2014-07       Impact factor: 5.853

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.